VolitionRx Limited (VNRX) Stock Forecast
Data as of May 4, 2026Healthcare · Current price $2.42 (+0.41%)
Consensus Target
—
Upside
—
Analysts
14
Rating
Buy(2.14)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Buy
Strong Buy0
Buy4
Hold1
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
VNRX vs Sector & Market
| Metric | VNRX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.14 | 2.24 | 2.41 |
| Analyst Count | 14 | 8 | 18 |
| Target Upside | — | +1148.8% | +14.9% |
| P/E Ratio | -0.64 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1M | $8M | $21M | 3 |
| 2027-12-31 | $4M | $50M | $137M | 3 |
| 2028-12-31 | $11M | $82M | $228M | 3 |
| 2029-12-31 | $24M | $172M | $483M | 2 |
| 2030-12-31 | $33M | $236M | $662M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.31 | $-0.09 | $0.01 | 2 |
| 2027-12-31 | $-0.03 | $0.12 | $0.26 | 2 |
| 2028-12-31 | $-0.13 | $0.24 | $0.81 | 3 |
| 2029-12-31 | $-0.07 | $0.60 | $2.01 | 1 |
| 2030-12-31 | $-0.10 | $0.81 | $2.73 | 1 |
Frequently Asked Questions
What is the analyst consensus for VNRX?
The consensus among 14 analysts covering VolitionRx Limited (VNRX) is Buy with an average price target of N/A.
How many analysts cover VNRX?
14 analysts have issued ratings for VolitionRx Limited in the past 12 months.
Is VNRX a buy or sell right now?
Based on 14 analyst ratings, VNRX has a consensus rating of Buy (2.14/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for VNRX?
Analysts estimate VNRX will report EPS of $-0.09 for the period ending 2026-12-31, with revenue estimated at $8M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.